Adult Growth Hormone Deficiency Market to Grow Positively at a Paltry CAGR During the Study Period | Terta Bio-pharma, WEX Pharmaceuticals, Intellia Therapeutics, Pharvaris Netherlands B.V., and others

DelveInsight's "Adult Growth Hormone Deficiency - Market Insight, Epidemiology and Market Forecast - 2032" report provides current treatment practices, emerging drugs, Adult Growth Hormone Deficiency market share of the individual therapies, current and forecasted Adult Growth Hormone Deficiency market size from 2019 to 2032 segmented by seven major markets. The report also offers current Adult Growth Hormone Deficiency therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Adult Growth Hormone Deficiency market.
Download sample report: https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Adult Growth Hormone Deficiency Overview
Adult-Onset Growth Hormone Deficiency (AGHD) is a medical condition that occurs when the body does not produce enough growth hormone. It stimulates the release of another hormone called insulin-like growth factor 1, which is produced mainly by the liver. Together, these hormones produce growth in childhood and, in adult life, have widespread metabolic effects throughout the body.
Most cases of adult onset growth hormone deficiency result from damage to the pituitary gland caused by the development of a pituitary tumor or by treatment for this using surgery and/or radiotherapy. Pituitary damage can also result from radiotherapy to the brain for other tumors close to the pituitary gland or for leukemia, from severe head injury, autoimmune disease or from interference with the blood supply to the pituitary gland (as for example in Sheehan's syndrome or pituitary apoplexy).
Types of AGHD based on Onset: Adults with AGHD fall into two categories which include: childhood onset (GHD began during childhood and has continued) and Adult onset (GHD developed after reaching adulthood). AGHD in adults is associated with premature mortality, increased adiposity or fat mass, as well as psychiatric-cognitive, cardiovascular, muscular, metabolic and skeletal abnormalities.
Request for a sample report @ https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Adult Growth Hormone Deficiency Epidemiological Insights
According to NORD Growth hormone deficiency affects males and females equally except for AGHD III which affects only males. However, given the greater concern for boys with short stature in most societies, diagnosis tends to favor males over females. 73% of patients with idiopathic AGHD in the NCGS were male. Additionally, patients with AGHD from organic causes such as tumors and radiation, in which no gender bias should be present, were still 62% male.
Promising Therapies in the Adult Growth Hormone Deficiency Pipeline
Sogroya (somapacitan-beco)
TransCon hGH
And others
Discover more about Adult Growth Hormone Deficiency therapies in the pipeline @ https://www.delveinsight.com/sample-request/adult-growth-hormone-deficiency-aghd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Leading Companies Working in the Adult Growth Hormone Deficiency Market
Novo Nordisk
Ascendis Pharma
And others
To understand key companies related to the Adult Growth Hormone Deficiency Market, get a snapshot of the Adult Growth Hormone Deficiency Regulatory and Patent Analysis https://www.delveinsight.com/sample-request/adult-growth-hormone-deficiency-aghd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Scope of the Adult Growth Hormone Deficiency Market Report
Study Period: 2019-2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan]
Key Adult Growth Hormone Deficiency Companies: Novo Nordisk, Ascendis Pharma, and others
Key Adult Growth Hormone Deficiency Pipeline Therapies: Sogroya (somapacitan-beco), TransCon hGH, and others
Therapeutic Assessment: Adult Growth Hormone Deficiency current marketed and emerging therapies
Adult Growth Hormone Deficiency Market Dynamics: Adult Growth Hormone Deficiency market drivers and barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Unmet Needs, KOL's views, Analyst's views, Adult Growth Hormone Deficiency Market Access and Reimbursement
Table of Contents
1. Adult Growth Hormone Deficiency Market Key Insights
2. Adult Growth Hormone Deficiency Market Report Introduction
3. Adult Growth Hormone Deficiency Market Overview at a Glance
4. Adult Growth Hormone Deficiency Market Executive Summary
5. Disease Background and Overview
6. Adult Growth Hormone Deficiency Treatment and Management
7. Adult Growth Hormone Deficiency Epidemiology and Patient Population
8. Patient Journey
9. Adult Growth Hormone Deficiency Emerging Drugs
10. 7MM Adult Growth Hormone Deficiency Market Analysis
11. Adult Growth Hormone Deficiency Market Outlook
12. Potential of Current and Emerging Therapies
13. KOL Views
14. Adult Growth Hormone Deficiency Market Drivers
15. Adult Growth Hormone Deficiency Market Barriers
16. Unmet Needs
17. SWOT Analysis
18. Appendix
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Trending Reports by DelveInsight:

Adalimumab Biosimilar Market | Arbovirus Infection Market | Artificial Pancreas Device System Market | Dental Equipment Market | Gluten Sensitivity Market | Hypothyroidism Market | Inflammatory Bowel Disease Market | Mayus Kinase Jak Inhibitors Market | Mild Dry Eye Market | Mucopolysaccharidosis Market | Oncolytic Virus Cancer Therapy Market | Pyoderma Gangrenosum Market | Transdermal Drug Delivery Devices Market | Intrathecal Pumps Market | Hedgehog Pathway Inhibitors Market | Yellow Fever Market | Laryngeal Cancer Market | Female Infertility Market | Gender Dysphoria Market | Chronic Brain Damage Market | Spain Healthcare Outlook Market | Malignant Fibrous Histiocytoma Market | Asthma Diagnostic Devices Market | Chronic Obstructive Pulmonary Disease Treatment Devices Market | Airway Management Devices Market | Cough Assist Devices Market | Pulse Oximeters Market | Hemodialysis Catheter Devices Market | Chronic Spontaneous Urticaria Market | Gender Dysphoria Market | Germany Healthcare Outlook | Biopsy Devices Pipeline Insight | Bacterial Conjunctivitis Market | Infliximab Biosimilar Insight | Eosinophilic Asthma Market | Cushing Syndrome Market | Functional Dyspepsia Market | Peripherally Inserted Central Catheters (PICC) Devices Market

Contact Us
Kritika Rehani
info@delveinsight.com
+14699457679

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.